New lessons from old pathogens: What parasitic infections have taught us about the role of nuclear factor-κB in the regulation of immunity

Immunological Reviews

Volumn 201, Issue , 2004, Pages 48-56

  Mason, Nicola J ^a   Artis, David ^a   Hunter, Christopher A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB;

ARTICLE; ENTERITIS; HOST RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNITY; LEISHMANIA MAJOR; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TOXOPLASMA GONDII; TRICHURIS;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; LEISHMANIA MAJOR; LEISHMANIASIS; MICE; NF-KAPPA B; TOXOPLASMA; TOXOPLASMOSIS; TRICHURIASIS; TRICHURIS;

EID: 4844230473     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2004.00189.x     Document Type: Article

References (64)

1. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-260.
2. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination. the control of NF-κB activity. Annu Rev Immunol 2000;18:621-663.
3. Ruland J, Mak TW. From antigen to activation: specific signal transduction pathways linking antigen receptors to NF-κB. Semin Immunol 2003;15:177-183.
4. Rothwarf DM, Karin M. The NF-κB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999:RE1.
5. Hedengren M, Asling B, Dushay MS, et al. Relish, a central factor in the control of humoral but not cellular immunity in Drosophila. Mol Cell 1999;4:827-837.
6. Rutschmann S, Jung AC, Hetru C, Reichhart JM, Hoffmann JA, Ferrandon D. The Rel protein DIF mediates the antifungal but not the antibacterial host defense in Drosophila. Immunity 2000;12:569-580.
7. Artis D, et al. Differential requirement for NF-κB family members in control of helminth infection and intestinal inflammation. J Immunol 2002;169:4481-4487.
8. Artis D, et al. NF-κB1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major. J Immunol 2003;170:1995-2003.
9. Caamano J, Alexander J, Craig L, Bravo R, Hunter CA. The NF-κB family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J Immunol 1999;163:4453-4461.
10. Caamano J, Hunter CA. NF-κB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev 2002;15:414-429.
11. Grigoriadis G, et al. The Rel subunit of NF-κB -like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO J 1996;15:7099-7107.
12. Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 1995;80:321-330.
13. Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 1992;149:175-180.
14. Hunter CA, Suzuki Y, Subauste CS, Remington JS. Cells and cytokines in resistance to Toxoplasma gondii. Curr Top Microbiol Immunol 1996;219:113-125.
15. Denkers EY, et al. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol 1997;159:1903-1908.
16. Khan IA, Ely KH, Kasper LH. Antigen-specific CD8+ T cell clone protects against acute Toxoplasma gondii infection in mice. J Immunol 1994;152:1856-1860.
17. Yoshimura S, Bondeson J, Brennan FM, Foxwell BM, Feldmann M. Role of NF-κB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur J Immunol 2001;31:1883-1893.
18. Grumont R, et al. c-Rel regulates interleukin 12 p70 expression in CD8 (+) dendritic cells by specifically inducing p35 gene transcription. J Ex Med 2001;194:1021-1032.
19. Murphy TL, Cleveland MG, Kulesza P, Magram J, Murphy KM. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol Cell Biol 1995;15:5258-5267.
20. Sanjabi S, Hoffmann A, Liou HC, Baltimore D, Smale ST. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc Natl Acad Sci USA 2000;97:12705-12710.
21. Yoshimoto T, Nagase H, Ishida T, Inoue J, Nariuchi H. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of NF-κB. Eur J Immunol 1997;27:3461-3470.
22. Mason N, Aliberti J, Caamano JC, Liou HC, Hunter CA. Cutting edge: identification of c-Rel-dependent and - independent pathways of IL-12 production during infectious and inflammatory stimuli. J Immunol 2002;168:2590-2594.
23. Butcher BA, Kim L, Johnson PF, Denkers EY. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB. J Immunol 2001;167:2193-2201.
24. Shapira S, Speirs K, Gerstein A, Caamano J, Hunter CA. Suppression of NF-κB activation by infection with Toxoplasma gondii. J Infect Dis 2002;185:S66-S72.
25. Kelsall BL, Biron CA, Sharma O, Kaye PM. Dendritic cells at the host-pathogen interface. Nat Immunol 2002;3:699-702.
26. Becker C, et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest 2003;112:693-706.
27. Franzoso G, et al. Mice deficient in nuclear factor NF-κB /p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med 1998;187:147-159.
28. Caamano J, et al. Identification of a role for NF-κB2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. J Immunol 2000;165:5720-5728.
29. Tato CM, Villarino A, Caamano JH, Boothby M, Hunter CA. Inhibition of NF-κB activity in T and NK cells results in defective effector cell expansion and production of IFN-γ required for resistance to Toxoplasma gondii. J Immunol 2003;170:3139-3146.
30. Mason NJ, Liou HC, Hunter CA. T cell-intrinsic expression of c-Rel regulates Th1 cell responses essential for resistance to Toxoplasma gondii. J Immunol 2004;171:3704-3711.
31. Sica A, Tan TH, Rice N, Kretzschmar M, Ghosh P, Young HA. The c-rel protooncogene product c-Rel but not NF-κB binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. Proc Natl Acad Sci USA 1993;89:1740-1744.
32. Brown DA, Kondo KL, Wong SW, Diamond DJ. Characterization of nuclear protein binding to the interferon-gamma promoter in quiescent and activated human T cells. Eur J Immunol 1992;22:2419-2428.
33. Bryan RG, et al. Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol Cell Biol 1994;14:7933-7942.
34. McGuire KL, Iacobelli M. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells. J Immunol 1997;159:1319-1327.
35. Shapiro VS, Truitt KE, Imboden JB, Weiss A. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol Cell Biol 1997;17:4051-4058.
36. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995;13:151-157.
37. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 1990;171:115-127.
38. Muller I, Garcia-Sanz JA, Titus R, Behin R, Louis J. Analysis of the cellular parameters of the immune responses contributing to resistance and susceptibility of mice to infection with the intracellular parasite, Leishmania major. Immunol Rev 1989;112:95-113.
39. Speirs K, Caamano J, Goldschmidt MH, Hunter CA, Scott P. NF-κB2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell Differentiation. J Immunol 2002;168:4406-4413.
40. Kamanaka M, et al. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 1996;4:275-281.
41. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996;4:283-289.
42. Garceau N, et al. Lineage-restricted function of NF-κB -inducing kinase (NIK) in transducing signals via CD40. J Exp Med 2000;191:381-386.
43. Ferlin WG, von der Weid T, Cottrez F, Ferrick DA, Coffman RL, Howard MC. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. Eur J Immunol 1998;28:525-531.
44. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003;3:733-744.
45. Finkelman FD, et al. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol 1997;15:505-533.
46. Artis D, Grencis RK. T helper cell cytokine responses during intestinal nematode infection: induction, regulation, and effector function. In: Kennedy, MW, Harnett, W, eds. Parasitic Nematodes: Molecular Biology, Biochemistry, and Immunology. New York: CABI Publishing, 2001:331-371.
47. Jenkins D, Wakelin D. Immunoepidemiology of intestinal helminth infections. 4. Immunopathology in trichuriasis: lessons from the mouse model. Trans R Soc Trop Med Hyg 1994;88:269-273.
48. Grencis RK. Enteric helminth infection: immunopathology and resistance during intestinal nematode infection. Chem Immunol 1997;66:41-61.
49. Helmby H, Takeda K, Akira S, Grencis RK. Interleukin (IL) -18 promotes the development of chronic gastrointestinal helminth infection by downregulating IL-13. J Exp Med 2001;194:355-364.
50. Bancroft AJ, Else KJ, Sypek JP, Grencis RK. Interleukin-12 promotes a chronic intestinal nematode infection. Eur J Immunol 1997;27:866-870.
51. Bancroft AJ, McKenzie AN, Grencis RK. A critical role for IL-13 in resistance to intestinal nematode infection. J Immunol 1998;160:3453-3461.
52. Else KJ, Finkelman FD, Maliszewski CR, Grencis RK. Cytokine-mediated regulation of chronic intestinal helminth infection. J Exp Med 1994;179:347-351.
53. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A. A critical role for NF-κB in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol 2001;2:45-50.
54. Svetic A, et al. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol 1991;147:2391-2397.
55. Erdman S, Fox JG, Dangler CA, Feldman D, Horwitz BH. Typhlocolitis in NF-κB - deficient mice. J Immunol 2001;166:1443-1447.
56. Groux H, Powrie F. Regulatory T cells and inflammatory bowel disease. Immunol Today 1999;20:442-445.
57. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002;16:219-230.
58. Hilliard BA, et al. Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J Clin Invest 2002;110: 843-850.
59. Sica A, et al. Interaction of NF-kB and NFAT with the IFN-g promoter. J Biol Chem Year 1999;7:30412-30420.
60. Shibuya K, et al. IL-1α and TNF-α are required for IL-12-induced development of Th1 cells producing high levels of IFN-γ in BALB/c but not C57BL/6 mice. J Immunol 1998;160:1708-1716.
61. Cai G, Kastelein R, Hunter CA. Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect Immun 2000;68:6932-6938.
62. Artis D, Humphreys NE, Bancroft AJ, Rothwell NJ, Potten CS, Grencis RK. TNF-α is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection. J Exp Med 1999;190:953-962.
63. Speirs K, Lieberman L, Caamano J, Hunter CA, Scott P. Cutting edge: NF-κB2 is a negative regulator of dendritic cell function. J Immunol 2004;172:752-756.
64. Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin M. The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 2003;9:575-581.